RT Journal Article
SR Electronic
T1 Personalizing the Pressure Reactivity Index for Neurocritical Care Decision Support
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.08.23289682
DO 10.1101/2023.05.08.23289682
A1 Briggs, Jennifer K.
A1 Stroh, J.N.
A1 Foreman, Brandon
A1 Park, Soojin
A1 ,
A1 Bennetty, Tellen D.
A1 Albersy, David J.
YR 2024
UL http://medrxiv.org/content/early/2024/06/27/2023.05.08.23289682.abstract
AB Neurocritical care patients may benefit from personalized treatment based on their cerebral autoregulatory function. The pressure reactivity index is an important, prevalent metric used to estimate the state of a patient’s cerebral autoregulation and guide clinical decision-making. However, the pressure reactivity index is highly sensitive to hyperparameter choices and intrapatient variability. In this manuscript, we develop a new personalized pressure reactivity index methodology (pPRx) that increases robustness and reduces the noise of the pressure reactivity index calculation. Using data from traumatic brain injury patients and simulated data, we first show that pressure reactivity index sensitivity to hyperparameters and interpatient variability is large enough to influence clinical interpretation of cerebral autoregulatory function. We identify that patient heart rate is closely related to errors in the pressure reactivity index, which has vital implications for extending the use of PRx to patients with different regular heart rates, such as pediatric populations. We then remove this heart rate-specific sensitivity in the pPRx methodology by adjusting for patient heart rate at resolutions of single heartbeats. Implementing the pPRx methodology decreases error, noise, and sensitivity, and allows the pressure reactivity index to be more robust to variability across patient populations. We also leverage our data and analysis to identify ideal averaging windows in the standard method.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by National Institutes of Health R01s LM006910 and LM012734 to DJA, and National Science Foundation (NSF) Graduate Research Fellowship DGE-1938058 Briggs to JKBAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee/IRB of the respective institutions enrolled in TRACK-TBI gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll simulated data and code will be made available at: https://github.com/jenniferkbriggs/PRxAnalysis.git Patient data can be requested by contacting TRACK-TBI. https://github.com/jenniferkbriggs/PRxAnalysis.git https://tracktbi.ucsf.edu/transforming-research-and-clinical-knowledge-tbi